Aclarion announced its Nociscan platform is now available at Goodman Campbell Brain & Spine at Ascension St. Vincent, marking the first site in Indiana to offer the technology. The addition extends Aclarion's provider network into a new state and aligns the company with a nationally recognized center for neurosurgery training and clinical research. Nociscan uses Magnetic Resonance Spectroscopy to extract and quantify chemical biomarkers associated with disc pain, providing objective, non-invasive insights that help physicians distinguish between painful and nonpainful discs in the lumbar spine. The platform demonstrates a 97% surgical success rate when all Nociscan-positive discs are treated. CEO Brent Ness stated that Goodman Campbell's reputation for clinical excellence and its role in training the next generation of neurosurgeons make them an important addition to the Nociscan network, reflecting growing momentum behind adoption of the technology.
Aclarion IncNociscan now available at a new site, expanding adoption and provider network.